Durham, North Carolina, USA
April 15, 2026
One of the world's most broad-reaching scientific institutions gains access to Pairwise's gene editing tools across plants, livestock, aquaculture, and microbes
Pairwise, a global innovator in precision breeding, today announced that CSIRO, Australia's national science agency, has signed a commercial license to Pairwise's Fulcrum® platform. The agreement is among the broadest licenses Pairwise has issued to date, covering plants, livestock, aquaculture, and microbes — putting Fulcrum's advanced gene editing capabilities directly in the hands of researchers across one of the world's largest and most diverse scientific research organizations.
CSIRO's mission spans the full breadth of Australian science and this agreement ensures that researchers have access to the Fulcrum® suite of CRISPR-based tools, including the SHARC™ enzyme, to accelerate discovery and innovation across a wide range of organisms and applications.
Dr Jason Geijskes, Trait Innovation Group Leader said CSIRO has a long history of delivering on farm impact in Australian agriculture systems through application of advanced breeding tools and technologies.
“Access to the Fulcrum® platform of precision breeding technologies will support the rapid development of traits which improve farm productivity and sustainability, and have direct benefits for consumers, across Australia and globally.”
"We are proud to announce this agreement with CSIRO, which will enable some of the world's most talented researchers to harness Fulcrum® across an extraordinary range of applications,” said Tom Adams, CEO of Pairwise. “The scope of this license is a reflection of just how versatile precision gene editing has become to address so many challenges.”
The Pairwise Fulcrum® platform includes gene editing tools, enzymes, and trait libraries that enable precise, targeted modifications across a wide range of organisms —accelerating scientific discovery and the development of solutions to some of the world's most pressing challenges.